Effectiveness and safety of follitropin alfa (Ovaleap®) for ovarian stimulation using a GnRH antagonist protocol in real-world clinical practice: a multicenter, prospective, open,...

por Sydow, Peter, Gmeinwieser, Norbert, Pribbernow, Katrin, Keck, Christoph, Wiegratz, Inka
Publicado 2020

Adherence with ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen supported by the use of a digital tablet dispenser with or without acoustic alarm: an open-la...

por Wiegratz, Inka, Elliesen, Jörg, Paoletti, Anna Maria, Walzer, Anja, Kirsch, Bodo
Publicado 2015

Oral Progestins in Hormonal Contraception: Importance and Future Perspectives of a New Progestin Only-Pill Containing 4 mg Drospirenone

por Römer, Thomas, Bitzer, Johannes, Egarter, Christian, Hadji, Peyman, Kiechle, Marion, Kramer, Heike, Oppelt, Patricia G., Peters, Klaus, Stute, Petra, Schaudig, Katrin, Wiegratz, Inka, Regidor, Pedro-Antonio
Publicado 2021

Correction: Oral Progestins in Hormonal Contraception: Importance and Future Perspectives of a New Progestin Only-Pill Containing 4 mg Drospirenone

por Römer, Thomas, Bitzer, Johannes, Egarter, Christian, Hadji, Peyman, Kiechle, Marion, Kramer, Heike, Oppelt, Patricia G., Peters, Klaus, Stute, Petra, Schaudig, Katrin, Wiegratz, Inka, Regidor, Pedro-Antonio
Publicado 2021